JAN (NYSE:JAN) Receives Average Rating of “Moderate Buy” from Analysts

Shares of JAN (NYSE:JAN) have earned an average rating of “Moderate Buy” from the fifteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $31.7143.

A number of brokerages have recently weighed in on JAN. Weiss Ratings initiated coverage on JAN in a research note on Thursday, August 6th. They issued a “hold (c-)” rating for the company. Scotiabank increased their price target on JAN from $30.00 to $31.00 and gave the company an “outperform” rating in a research note on Wednesday, September 2nd. Wells Fargo & Company upped their target price on shares of JAN from $33.00 to $35.00 and gave the company an “overweight” rating in a research note on Tuesday, September 1st. Huntington assumed coverage on JAN in a report on Thursday. They issued an “outperform” rating and a $36.00 price target for the company. Finally, JPMorgan Chase & Co. raised their price objective on shares of JAN from $30.00 to $34.00 and gave the stock an “overweight” rating in a report on Tuesday, August 18th.

JAN Price Performance

NYSE:JAN opened at $30.76 on Friday. The business has a 50-day simple moving average of $30.34. JAN has a 12-month low of $22.76 and a 12-month high of $32.83.

JAN (NYSE:JAN) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.18). The business had revenue of $216.46 million during the quarter, compared to the consensus estimate of $203.32 million. JAN’s revenue was up 45.4% compared to the same quarter last year. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. Equities analysts predict that JAN will post 0.97 EPS for the current fiscal year.

JAN Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Friday, September 11th will be issued a dividend of $0.0475 per share. The ex-dividend date is Friday, September 11th. This represents a c) annualized dividend and a yield of 1.9%.

Key Stories Impacting JAN

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Huntington’s “Outperform” rating and $36 target provide a new positive valuation signal and suggest the analyst sees potential for further appreciation. JAN receives Huntington Outperform rating and $36 price target
• Neutral Sentiment: A recent article about JAN-PRO of San Antonio outlined cleaning requirements for hotels and hospitality. The item may support brand visibility and franchise activity, but it contained no specific financial guidance or material company-wide update. JAN-PRO hospitality cleaning requirements
• Negative Sentiment: Investor sentiment remains constrained by JAN’s latest quarterly earnings miss: adjusted earnings were $0.05 per share versus a $0.23 consensus estimate, even though revenue reached $216.46 million and increased 45.4% year over year. The earnings shortfall may be outweighing the new analyst optimism in the near term.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Engineers Gate Manager LP acquired a new stake in shares of JAN in the 2nd quarter valued at approximately $15,274,000. Readystate Asset Management LP bought a new stake in shares of JAN during the 2nd quarter worth about $1,724,000. Greenland Capital Management LP bought a new position in JAN during the 2nd quarter worth $575,000. Wellington Management Group LLP bought a new stake in JAN in the 2nd quarter valued at about $8,739,000. Finally, WINTON GROUP Ltd bought a new stake in shares of JAN in the second quarter valued at approximately $2,985,000. 6.27% of the stock is owned by institutional investors and hedge funds.

About JAN

JanOne Inc is a technology and life sciences company focused on addressing the global opioid crisis. The company’s activities include developing and supporting pharmaceutical and other solutions intended to help reduce opioid-related deaths and dependency.

JanOne has also pursued blockchain and financial technology initiatives through its Alt 5 Sigma operations. These activities have included blockchain-based payment, digital asset and financial services solutions designed to help businesses manage transactions and related digital assets.

The company serves markets through its healthcare, technology and financial services initiatives, with an emphasis on solutions that can be applied internationally.